This topic contains a solution. Click here to go to the answer

Author Question: A patient is using a flow-dependent incentive spirometer. The patient is achieving an inspiratory ... (Read 60 times)

WWatsford

  • Hero Member
  • *****
  • Posts: 539
    • Biology Forums!
A patient is using a flow-dependent incentive spirometer. The patient is achieving an inspiratory flow of 275 mL/sec. The patient is able to sustain this flow for 3 seconds. What volume did the patient inhale?
 A) 275 mL
  B) 550 mL
  C) 825 mL
  D) 1,100 mL

Question 2

The appropriate treatment for hypocalcemia as a result of premature birth is
 A) administration of calcium
  B) administration of potassium
  C) ventilatory support
  D) calcium restriction



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

leahchrapun

  • Sr. Member
  • ****
  • Posts: 332
Answer to Question 1

C

Answer to Question 2

A




WWatsford

  • Member
  • Posts: 539
Reply 2 on: Jul 16, 2018
YES! Correct, THANKS for helping me on my review


  • Member
  • Posts:
Reply 3 on: Yesterday
Excellent

 

Did you know?

A serious new warning has been established for pregnant women against taking ACE inhibitors during pregnancy. In the study, the risk of major birth defects in children whose mothers took ACE inhibitors during the first trimester was nearly three times higher than in children whose mothers didn't take ACE inhibitors. Physicians can prescribe alternative medications for pregnant women who have symptoms of high blood pressure.

Did you know?

Drug-induced pharmacodynamic effects manifested in older adults include drug-induced renal toxicity, which can be a major factor when these adults are experiencing other kidney problems.

Did you know?

Illicit drug use costs the United States approximately $181 billion every year.

Did you know?

Drying your hands with a paper towel will reduce the bacterial count on your hands by 45–60%.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library